Revelation Biosciences, Inc. (REVBW) — This stock currently has no analyst coverage. No price targets, ratings, or earnings estimates are available. This is common for preferred shares, warrants, OTC-traded securities, and smaller companies that are not followed by Wall Street analysts.
Los analistas estiman Beneficio por acción (EPS) de $-1,436.16 y ingresos de $0.00B para el próximo año fiscal.
Historial de Beneficio por acción (EPS): 2024: real $-9.44 vs est $-1,436.16 (superó +99.3%). 2025: real $-23.95 vs est $-36.60 (superó +34.6%). Precisión del analista: 0%.
